Category Archives: Top Market News

JMP Securities Remains a Buy on Syros Pharmaceuticals (SYRS)

In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on Syros Pharmaceuticals (SYRS – Research Report), with a price target of $20.00. The company’s shares closed last Monday at $4.98, close to its 52-week low

Monday’s Midday Movers: AVEO Pharma (AVEO), First Solar (FSLR), Aerie Pharma (AERI), Renesola (SOL), Agenus (AGEN)

So far Monday, September 20, NASDAQ is down -0.45% and the S&P is down -3.13%. Here are this morning’s most active stocks: AVEO Pharma (AVEO – Research Report), First Solar (FSLR – Research Report), Aerie Pharma (AERI – Research Report),

Why Did Colliers Securities Upgrade Astronics’ Stock?

In a report released today, Richard Ryan from Colliers Securities upgraded Astronics (ATRO – Research Report) to Buy, with a price target of $19.00. The company’s shares closed last Friday at $12.61. According to TipRanks.com, Ryan is a 4-star analyst

Verastem (VSTM) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Sean Lee CFA maintained a Buy rating on Verastem (VSTM – Research Report) today and set a price target of $5.00. The company’s shares closed last Friday at $2.76. According to TipRanks.com, CFA is a 4-star analyst

Gritstone Oncology (GRTS) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Sean Lee CFA maintained a Buy rating on Gritstone Oncology (GRTS – Research Report) today and set a price target of $24.00. The company’s shares closed last Friday at $11.50. According to TipRanks.com, CFA is a 4-star

Analysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Protagonist Therapeutics (PTGX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Regeneron (REGN – Research Report), Protagonist Therapeutics (PTGX – Research Report) and Corcept Therapeutics (CORT – Research Report) with bullish sentiments. Regeneron